Starlight Therapeutics is a precision oncology company focused solely on CNS (central nervous system) cancers, primarily brain cancers. The company is developing a drug candidate known as STAR-001 for CNS cancers, aiming to address the limited therapeutic options available.
peer of
Metrics
marketPRIVATE
msh_idCOM:STARLIGHTTHERA
localeus
websitehttps://www.starlightthera.com/
source_refeebe8475-cdea-4a1b-9046-9cc61a74460f
products_or_servicesDevelopment of drug candidate STAR-001 for CNS cancers and participation in clinical trials.
United States